Aegerion Pharmaceuticals (AEGR +8.8%) trades up in reaction to a positive FDA staff report on...

|About: Aegerion Pharmaceuticals (AEGR)|By:, SA News Editor

Aegerion Pharmaceuticals (AEGR +8.8%) trades up in reaction to a positive FDA staff report on its drug lomitapide. The drug treats a rare genetic disorder that causes very high cholesterol, and the report said that AEGR's plan to manage risk associated with it supports approval in adults with the most life-threatening forms. The drug is due to be reviewed on Wednesday by a committee of non-FDA medical experts, and the FDA will make a final decision by the end of December.